ACE2 and COVID-19: Studies investigating the neurovirological manifestations of COVID-19 are being conducted increasingly, as growing evidence demonstrates the ability of the virus to cross the blood-brain barrier and due to involvement of angiotensin-converting enzyme 2 (ACE2) receptor (77).